AdExplore Verzenio® as a treatment option for your patients. Visit the website to find helpful resources for your patients.

AdA Key Goal In First-Line HR+ mBC Is To Maximize Patients' Time On Endocrine Therapy. Aromatase Inhibitors Exposure May Lead To Endocrine Resistance In 1L Endocrine Therapy.